OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
September 12, 2023
How drugmakers can navigate the program’s pricing challenges and regulatory developments.
August 25, 2023
Shift focus in orphan and ultra-orphan messaging to clinical benefit.
August 08, 2023
The August issue varies in subject matters, from the outlook for drug wholesaling to the value of a user-centric approach for drug adherence.
As Pharma Commerce continues to increase its conference exposure, it all could not have been possible without the help of colleagues.
July 21, 2023
The importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.
July 07, 2023
Micah Litow, Kalderos’ president and COO, discusses the importance of identifying and resolving noncompliant discount requests, along with addressing the gross-to-net gap for drug manufacturers.
June 26, 2023
The legislation’s deadline for compliance is knocking on the door. Pharma Commerce offers a synopsis of how the Drug Supply Chain Security Act has progressed over the past decade.
June 05, 2023
The publication's June installment features a plethora of coverage, ranging from the learning curve in digital adoption to an overview of the CVD market.
As the brand looks to increase its coverage, Pharma Commerce welcomes a pair of editorial contributors to the team.
April 07, 2023
Although there is no ‘one size fits all’ solution, the process is influenced by factors such as lifestyle stage, competitive outlook, and market constraints.